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ABSTRACT
OBJECTIVE: To assess incidence and predictors of fi rst pregnancy among 
women with HIV/AIDS.
METHODS: Prospective cohort study was conducted in Rio de Janeiro, 
southeastern Brazil, between 1996 and 2003. This study comprised 225 women 
with HIV/AIDS followed up until their fi rst pregnancy or fi rst censored event 
(hysterectomy, tubal ligation, menopause, 50 years of age, loss to follow-up, 
death or the end of December 2003). Pregnancy and abortion rates were 
estimated, and Cox proportional hazards models were used to identify baseline 
characteristics associated with pregnancy risk.
RESULTS: The women were followed up for 565 person/years with a median 
follow-up of 3 years per women. The mean age was 32 years (SD: 7), and 
54.7% were white. There were 60 pregnancies in 39 women, and 18 were 
terminated (induced abortions), accounting for a rate of 6.9% and 2.1% women/
year, respectively. Repeated pregnancies occurred in 33.3% of the women 
(13/39). Higher pregnancy risk was seen among younger women (HR=3.42; 
95%CI: 1.69;6.95) and those living with their partners (HR=1.89; 95%CI: 
1.00;3.57). Lower pregnancy risk was associated with higher education level 
(HR=0.43; 95%CI: 0.19;0.99) and use of antiretroviral therapy (HR=061; 
95%CI: 0.31;1.17).
CONCLUSIONS: Lower pregnancy rates were found in our cohort than in 
the general population. Sociodemographic characteristics should be taken 
into consideration in the management of reproductive health in HIV-positive 
childbearing age women. Reproductive and family planning counseling must 
be incorporated into HIV/AIDS programs for women to help preventing HIV 
transmission to their partners and offspring.
DESCRIPTORS: HIV Infections. Pregnancy. Risk Factors. Cohort 
Studies.
Artigos Originais
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Most women living with HIV/AIDS worldwide are 
childbearing age.a HIV infection in women constitutes 
a major public health issue beyond its direct impact on 
women’s health. Both the risk of mother-to-child trans-
mission (MTCT) of HIV and transmission to uninfected 
male sexual partners must be considered in any public 
health program targeting women with HIV/AIDS. This 
is particularly important in developing countries where 
most new cases of HIV infections occura and where 
defi cient health care infrastructure and constrained 
budgets may jeopardize the implementation of care 
and prevention programs.b
With the advent of highly active antiretroviral therapy 
(HAART), the mortality and morbidity associated with 
HIV infection have been signifi cantly reduced,6,15,21 
RESUMO
OBJETIVO: Identifi car incidência e preditores incidência da primeira gestação 
entre mulheres com HIV/Aids.
MÉTODOS: Estudo prospectivo de coorte conduzido entre 1996 e 2003 no 
Rio de Janeiro, RJ, com 225 mulheres acompanhadas até a primeira gestação 
ou até o primeiro evento considerado censura (histerectomia, ligadura tubárea, 
menopausa, 50 anos de idade, perda de acompanhamento, óbito ou fi nal 
de dezembro de 2003). Taxas de incidência de gestação e de aborto foram 
estimadas e modelos de riscos proporcionais de Cox foram usados para 
identifi car as características da visita de inclusão associadas com o risco de 
gestação.
RESULTADOS: As mulheres foram acompanhadas por 565 pessoas/ano, com 
média de acompanhamento de 3 anos por mulher. A idade média foi de 32 anos 
(DP: 7) e 54,7% eram brancas. Sessenta gestações foram observadas em 39 
mulheres e 18 resultaram em abortos induzidos (taxas de incidência de 6,9% 
e 2,1% mulheres/ano, respectivamente). Gestações repetidas ocorreram em 
33,3% das mulheres (13/39). Maior risco de gestação foi observado entre 
mulheres jovens (HR = 3,42; IC95%:1,69;6,95) e entre aquelas vivendo com 
seus parceiros (HR = 1,89; IC95%:1,00;3,57). Menor risco de gestação esteve 
associado à maior escolaridade (HR = 0,43; IC95%:0,19;0,99) e ao uso de 
terapia anti-retroviral (HR = 0,61; IC95%:0,31;1,17).
CONCLUSÕES: A incidência de gestação na coorte foi menor se comparada 
àquela observada na população geral. Características sociodemográfi cas 
devem ser consideradas no manejo dos desejos reprodutivos de mulheres 
HIV-positivas em idade reprodutiva. Os programas de HIV/Aids devem incluir 
aconselhamento reprodutivo e contraceptivo para prevenir a transmissão do 
HIV para seus parceiros e prole.
DESCRITORES: Infecções por HIV. Gravidez. Fatores de Risco. Estudos 
de Coortes.
INTRODUÇÃO
a Joint United Nations Program on HIV/AIDS – UNAIDS. Report on the Global HIV/AIDS Epidemic – 2008 [Internet]. [cited 2008 Jul 31]. 
Available from: http://whqlibdoc.who.int/unaids/2008/9789291737116_eng.pdf
b Joint United Nations Program on HIV/AIDS – UNAIDS. Where prevention and care meet: voluntary counseling and testing and prevention 
mother-to-child transmission: Report on the Global HIV/AIDS Epidemic. Geneva; 2005.
c Ministério da Saúde. Aids em pessoas com 50 anos ou mais de idade. Bol Epidemiol AIDS/DST. 2008;5(1):1-58
improving the quality of life of people with HIV/
AIDS.14 In addition, treatment with HAART combined 
with elective cesarean delivery and the use of milk from 
milk banks or formula instead of breastfeeding can 
reduce MTCT to less than 2%.17 In settings where these 
interventions are available, increasing pregnancy rates 
among women with HIV/AIDS have been reported.5,11 
Reproductive choices, especially childbearing, have 
become a more complex issue in the development of 
prevention and care programs.
According to the Brazilian Ministry of Health, women 
accounted for 34.2% of 506,499 AIDS cases reported 
in mid-2008, and more than 12,000 women with HIV/
AIDS give birth each year.c Despite a comprehen-
sive care program to people living with HIV/AIDS, 
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including widespread free provision of HAART has 
been implemented since 1996, there are no data avail-
able about pregnancy rate or predictors of pregnancy 
in women with HIV/AIDS in Brazil.
The present study aimed to estimate pregnancy rate 
and identify baseline predictors of fi rst pregnancy in 
women with HIV/AIDS.
METHODS
Data from the Instituto de Pesquisa Clínica Evandro 
Chagas (IPEC) Cohort of Women Living with HIV/
AIDS followed up in Fundação Oswaldo Cruz 
(FIOCRUZ) Rio de Janeiro, southeastern Brazil, were 
used. This cohort is an ongoing prospective study of 
the natural history of HIV infection and related health 
conditions among women with HIV/AIDS. All women 
aged 18 or older who were receiving primary HIV care 
at IPEC HIV/AIDS clinic were invited to participate in 
this cohort study. The women who agreed to participate 
and signed an informed consent form were prospectively 
followed up and underwent gynecological/obstetric 
and behavioral evaluations. Follow-up visits were 
completed yearly up to 2003 and every six months since 
then. At each visit, the participants were interviewed 
confi dentially using a standardized questionnaire to 
collect information on social and reproductive history 
and sexual behavior. Drug and alcohol use were also 
assessed. Counseling on reproductive health, safe sex 
and risk reduction was provided for all participants 
during routine visits or additional visits as needed. 
Women were clinically followed up as recommended 
by the Brazilian Ministry of Health guidelines and were 
monitored through CD4+ T-lymphocyte cell counts 
and gynecological examinations. Medical histories and 
laboratory results were obtained from medical records. 
The clinical and laboratorial procedures of this cohort 
have been detailed elsewhere.10
A total of 402 women with HIV/AIDS were enrolled 
in the cohort between June 1996 and February 2003.
A prospective analysis of pregnancy among child-
bearing women with HIV/AIDS at the time of enroll-
ment in the cohort was conducted. Women who were 
not at risk of getting pregnant were not included in 
this study: those who were pregnant (n=21), post-
menopausal (n=21), hysterectomized (n=13) or 
sterilized (n=70) at baseline, as well as those aged 50 
years or older (n=10). Women who attended only one 
visit during the monitoring period were also excluded 
(n=42). The fi nal sample comprised 225 women with 
HIV/AIDS.
The women were followed up from their admission 
to this cohort up to the end of December 2003, which 
allowed women enrolled in late 2002 and in the fi rst 
two months of 2003 to attend a second follow-up visit.
The outcome of interest was evaluated in every follow-
up visit through the following question: “Did you get 
pregnant in the past six months?”. Medical records 
were reviewed to identify inconsistencies and women 
with missing cohort visits or lost to follow-up. These 
women were contacted to clarify inconsistencies.
The following baseline explanatory variables were 
included in the analysis: age (years), skin color/
ethnicity (self-reported), level of education (years), 
monthly family income (in Brazilian minimum wages), 
number of living children, marital status, number of 
lifetime partners, age of sexual initiation, history of 
sexual abuse, history of domestic violence, history of 
prior sexually transmitted infections (STIs), alcohol 
use (“When you drink alcohol, how many drinks do 
you usually have?”), lifetime illicit drug use (inhaled 
and injected illicit drugs and other drugs used to get 
high, either prescription and non-prescription drugs), 
baseline CD4+ T cell count, use of antiretrovirals 
at baseline and HIV-related conditions prior to the 
baseline visit.
Pregnancy and abortion rates were estimated as 100 
persons/year (PY). We fi tted Cox proportional hazards 
models to identify factors associated with the risk of 
a woman getting pregnant. Women who underwent 
hysterectomy (1.3%) or tubal ligation (8.0%) and 
who reported menopause (5.7%) after entering the 
cohort were censored. Observations when women 
turned 50 (2.2%) and were lost to follow-up (4.0%) 
or died (6.7%) were also censored. Loss to follow-up 
was defi ned as no gynecological follow-up visits after 
December 2002 or no clinical records in their charts. 
Women were censored at the time of the occurrence 
of the fi rst of these events.
The analysis was performed in two stages. An unad-
justed model was fi tted and all covariates statistically 
signifi cant at 25% were selected. In the second stage, 
a multiple analysis was performed, and the covariates 
statistically signifi cant at 5% (p-value ≤ 0.05) remained 
in the model. The variable “use of antiretrovirals” 
was included in the model, regardless of its statistical 
signifi cance, as it was our main explanatory variable of 
interest. The assumption of proportionality in the Cox 
proportional hazards models was tested by including 
interactions between the variable “time” and other 
covariates.1 To validate the fi nal model, an analysis 
of residuals was conducted. The data were analyzed 
using SAS.22 The explanatory variables included in the 
present analysis were assessed at baseline (Table 1).
The study protocol was approved by the Research 
Ethics Committee of IPEC/FIOCRUZ and all partici-
pants signed an informed consent form (Process Nr. 
0023.0.009.000-3, 08/12/2003).
376 Pregnancy in HIV/AIDS women Friedman RK et al
RESULTS
The mean age of the women included in the analysis 
was 32 years (standard deviation [SD]: 7), and 60% 
were 30 years or older (Table 1). Nearly half of the 
women were self-reported white (54.7%), and 35.1% 
reported having no more than three years of educa-
tion. Overall, 49.1% were employed at baseline, and 
the majority (75.1%) had a monthly family income 
of fi ve minimum wages. Less than one-third (30.2%) 
were married/living with a partner at the time of their 
enrollment in the cohort, and 76.4% had at least one 
living child. The proportion of women who reported 
HIV-infected children was 20.1%.
Almost one-third of the women (32.0 %) reported alcohol 
use, and 81 (36.0%) reported having used illicit drugs; 
8.6% (7/81) reported lifetime use of injected drugs. The 
mean number of lifetime sexual partners reported at 
baseline was 9.6 (SD: 19.3; median: 4 partners) and the 
mean age of sexual initiation was 17.9 years (SD: 3.7). 
Sexual abuse and domestic violence were reported by 
20.9% and 24.4% of the women, respectively. About half 
of the sample reported history of other STIs.
The average CD4+ T-lymphocyte cell count at base-
line was 397 cells/mm3, and 27.6% of the women had 
counts below 200 cells/mm3. History of opportunistic 
infection was reported at baseline by about one-fourth 
(24.0%) of the women.
Approximately 90.0% reported at least one previous 
pregnancy. The average number of pregnancies was 2.6. 
The mean age of the fi rst pregnancy was 20.6 years (SD: 
5.0). Induced and spontaneous abortion was reported by 
41.8% and 25.8% of the women, respectively.
The women were followed for a total of 565 person/
years with a median follow-up of 3 years per women. 
Table 1. Sociodemographic, behavioral and clinical 
characteristics of childbearing women with HIV/AIDS at 
the time of their inclusion in the cohort. Rio de Janeiro, 
Southeastern Brazil, 1996–2003. (N = 225)
Characteristic n %
Age (years)
< 30 90 40.0
≥ 30 135 60.0
Skin color/ethnicity
White 123 54.7
African-Brazilian / Black 39 17.3
Mixed 63 28.0
Level of education (years)
0–3 79 35.1
4–8 63 28.0
9 or more 83 36.9
Monthly family income 
(minimum wages)
< 2 93 41.3
2–5 76 33.8
> 5 55 24.4
Number of living children 
None 53 23.6
One or more 172 76.4
Marital status
Married/living with a 
partner
68 30.2
Not living with a partner 157 69.8
Number of lifetime sexual 
partners
0–10 189 84.0
> 10 36 16.0
Age of sexual initiation (years)
≤ 16 88 39.1
> 16 137 60.9
History of sexual abuse
Yes 47 20.9
No 178 79.1
History of domestic violence
Yes 55 24.4
No 170 75.6
History of other STIs
Yes 109 48.4
No 116 51.6
Alcohol use
None 153 68.0
1–2 drinks 23 10.2
3 drinks or more 49 21.8
To be continued
Table 1 continuation
Characteristic n %
Lifetime use of illicit drugs
Yes 81 36.0
No 144 64.0
Baseline CD4+ cell count
< 200 62 27.6
≥ 200 163 72.4
Antiretroviral use
Yes 147 65.3
No 78 34.7
HIV-related conditions
Yes 54 24.0
No 171 76.0
STI: sexually transmitted infection
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Among the 225 women included in this analysis, 17.0% 
(n=39) got pregnant at least once after their enrollment 
in the cohort. Repeated pregnancies were seen in 33.3% 
(13/39) of the women who became pregnant after the 
baseline assessment. Overall, 60 pregnancies were 
recorded for 39 women during the study period. The 
pregnancy rate in this population during the study period 
was 6.9% (95% CI 5.2;8.6) women/years of follow-up.
Pregnancy outcome data were available for 58 out of 
the 60 reported pregnancies; there were 31 (53.4%) 
deliveries (with one set of twins), 9 (15.5%) sponta-
neous abortions and 18 (31.0%) induced abortions. The 
Table 2. Unadjusted hazard ratios for pregnancy in women 
in the study. Rio de Janeiro, Southeastern Brazil, 1996–2003. 
(N = 225)
Characteristic
Hazard 
ratio
95%CI
Age (years)
< 30 3.68a 1.83;7.39
≥ 30 1 -
Skin color/ethnicity
White 1 -
African-Brazilian / Black 0.76 0.31;1.85
Mixed 0.62 0.28;1.38
Level of education (years)
0–3 1.00 -
4–8 0.99 0.48;2.03
9 or more 0.52c 0.23;1.17
Monthly family income (minimum 
wages)
< 2 1.18 0.53;2.61
2–5 0.86 0.36;2.08
> 5 1 -
Number of living children
None 1 -
One or more 0.94 0.46;1.93
Marital status
Married/living with a partner 2.08a 1.11;3.90
Not living with a partner 1 -
Number of lifetime sexual partners
0–10 1 -
> 10 1.11 0.49;2.53
Age of sexual initiation (years)
≤ 16 1.76b 0.96;3.36
> 16 1 -
History of sexual abuse
Yes 1.27 0.62;2.62
No 1 -
History of domestic violence
Yes 1.14 0.57;2.29
No 1 -
Other prior STIs
Yes 0.87 0.46;1.63
No 1 -
Alcohol use
None 1 -
1 to 2 drinks 2.04c 0.84;4.98
3 drinks or more 0.80 0.35;1.84
Lifetime use of illicit drugs
Yes 1.19 0.63;2.26
No 1 -
To be continued
Table 2 continuation
Characteristic
Hazard 
ratio
95%CI
Antiretroviral use
Yes 0.52a 0.28;0.97
No 1 -
Baseline CD4+ cell count
< 200 0.56c 0.23;1.33
≥ 200 1 -
HIV-related conditions
Yes 0.71 0.30;1.70
No 1 -
a p<0.05
b p<0.10
c p<0.25
STI: sexually transmitted infection
Table 3. Adjusted hazard ratios for pregnancy in women in 
the study. Rio de Janeiro, Southeastern Brazil, 1996–2003. 
(N = 225)
Characteristic
Hazard 
ratio
95%CI
Age (years)
< 30 3.42a 1.69;6.95
≥ 30 1 -
Marital status
Married/living with a partner 1.89b 1.03;3.67
Other 1 -
Level of education (years)
0–3 1 -
4–8 0.69 0.32;1.47
9 or more 0.43a 0.19;0.99
Antiretroviral use
Yes 0.61c 0.31;1.17
No 1 -
a p<0.05
b p = 0.05
c p<0.15
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rate of induced abortion was 2.1% (95%CI 1.2%;3.0%) 
women/years of follow-up. Only one baby was born 
HIV infected.
Pregnancy was seen in 12.2% of the women who were 
on antiretroviral therapy (ART) at baseline (n=147) and 
in 26.9% of those who were ART naive (n=78). Among 
the women who got pregnant during the follow-up 
period (n=39), 46.1% were on ART at baseline.
The hazard ratios (HR) and their related confi dence 
intervals (CIs) obtained from the unadjusted Cox 
proportional hazards models are presented in Table 2. 
Skin color/ethnicity, monthly family income, number 
of living children, lifetime number of partners, history 
of sexual abuse, history of domestic violence, other 
prior STIs, use of illicit drugs and HIV-related condi-
tion did not show a clear association with pregnancy. 
Age, level of education, marital status, age of sexual 
initiation, alcohol use, use of antiretrovirals and CD4+ 
T cell count were associated with the risk of pregnancy 
at a 25% signifi cance level (p<0.25). These variables 
were included in the multivariate models.
The results of the adjusted Cox proportional hazards 
model are shown in Table 3. Age, marital status and 
level of education were found to be independent predic-
tors of pregnancy. Women under 30 were 2.4 times 
more likely to become pregnant than those aged 30 or 
older (HR = 3.42; 95%CI 1.69;6.95). A higher risk of 
pregnancy was also found among women living with 
a partner (HR = 1.89; 95%CI 1.00;3.57). In contrast, 
education showed an inverse relationship with the 
risk of pregnancy. Women with nine or more years 
of education had a 57% lower risk of pregnancy than 
those with up to three years of education (HR = 0.43; 
95%CI 0.19;0.99). The risk of pregnancy was 39% 
lower, although not signifi cantly different (p = 0.11), 
in women receiving ART compared to those not on 
therapy (HR = 061; 95%CI 0.31;1.17).
DISCUSSION
The pregnancy rate in our cohort was two-third of 
that seen in same-age Brazilian women in the general 
population. However, the rate of induced abortion found 
suggests that pregnancy was not desired in some cases. 
The study also showed that younger, less educated, and 
those women living with their spouses/partners were 
more likely to become pregnant.
International studies, both in the pre- and post-HAART 
eras, have reported inconsistent fi ndings regarding 
reproductive decisions of women with HIV/AIDS.4,7-
9,13,24 Data are available for both high- and low-income 
countries, but to date there is limited data from Brazil, a 
middle-income country where HAART has been widely 
available at no cost at the point of delivery since 1996.
In our study we found a pregnancy rate of 6.9% 
women/year. Based on the number of childbearing 
women, number of live births corrected for under-
reporting/delays, number of fetal losses including 
stillbirths,d and number of induced or spontaneous 
abortionse for the year 2000, we estimated a preg-
nancy rate of 10.4 pregnancies per 100 childbearing 
women in the general Brazilian population. This rate 
was similar to that reported by Ventura et al in the 
US.25 The pregnancy rate found in women with HIV/
AIDS in our study was 66% of the estimated national 
rate, refl ecting the need of giving special attention to 
reproductive demands of this population.
The pregnancy rate found in our study was substantially 
lower than the rate of 12.3% women/year seen in a study 
carried out among 306 HIV-infected women in Burkina 
Faso, Sub-Saharan Africa,18 but it is comparable to 
annual pregnancy rates reported in two US studies. 
In the fi rst one, a pregnancy rate of 5.5% women/year 
was found by Blair et al (2004) in a longitudinal study 
of 8,857 women aged 15 to 44 years followed up from 
1992 to 2001.5 In the second one, Massad et al (2004)16 
reported an annual pregnancy rate of 7.4% women/
year in a cohort of 1,271 HIV-infected women. In all 
three studies, only childbearing women were consid-
ered exposed to the risk at baseline. In Massad et al16 
study (2004), all women who had had a hysterectomy, 
bilateral oophorectomy or tubal sterilization, were 50 
years of age or reported no vaginal intercourse for 12 
months were censored during follow-up16 – all criteria 
similar to those used in our study.
Unplanned pregnancy is apparently a major event 
among HIV-infected women, although contraceptive 
use seems to increase in the context of treatment roll-
out.2 It is diffi cult to assess in some women when a 
pregnancy is actually desired or not. The rate of induced 
abortion was remarkable in our study (31.0%) and was 
higher than the overall rate of 17.7% in childbearing 
women reported by Barbosa et al3 (2009) in a study 
conducted in 13 municipalities in Brazil. They reported 
a rate of induced abortion in southeast Brazil of 23.1%.
It is possible that Rio de Janeiro has contributed to 
the increase in the region’s induced abortion rate.3 In 
our study, we found an induced abortion rate of 31%, 
2.1% women/year. Studies in different backgrounds 
have found a wide range of induced abortion rates 
(19%–53%).9,23,24 The abortion rate should be inter-
preted in the context of a developing country where 
d Datasus. Rede Interagencial de Informações em Saúde – RIPSA. Indicadores e dados básicos – Brasil – 2006 [Internet]. [cited 2007 May 16]. 
Available from: http://tabnet.datasus.gov.br/cgi/idb2006/matriz.htm
e Monteiro MFG, Adesse L. Estimativas de aborto induzido no Brasil e Grandes Regiões (1992-2005). In: Anais do 15. Encontro Nacional de 
Estudos Populacionais – ABEP; 2006; Caxambu, Brasil. p.1-10.
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induced abortion is illegal and its complications are a 
major cause of death.20
As expected, we found a higher pregnancy risk among 
women younger than 30, consistent to that reported 
by Levin et al (2004) in a study of adolescents in 
the US.12 In fact, younger age proved to be a strong 
pregnancy predictor, which is corroborated in other 
studies. 4,5,7,8,13,16
Marital stability was also signifi cantly associated with 
pregnancy. Women living with their sexual partners were 
more likely to get pregnant than women who did not. 
A similar fi nding was described by Maier et al (2009) 
between 2005 and 2006 in Uganda.13 Van Benthem 
et al (2000) also reported lower risk of pregnancy 
among single women as compared to women in stable 
marriages.24 In contrast, Massad et al (2004) found 
that single women had a 60% higher risk of pregnancy 
than married women (OR 1.59; 95%CI 1.02;2.44).16 
Although there are some differences in the modeling 
strategies used in these three studies, the contrasting 
results may be suggestive of cultural differences in the 
communities studied. However, we did not assess in the 
present study the role of women’s partners and reproduc-
tive desires of men or women, which may contribute 
to higher pregnancy rates. The role of men and gender 
differences must be evaluated by health providers 
providing care to couples living with HIV/AIDS.
Education level was found to be an important pregnancy 
predictor in the present study: the higher the level of 
education, the lower the pregnancy risk. According to 
the 2000 Brazilian census data, the infl uence of educa-
tion level on fertility can be seen nationwide. Women 
with more years of education have fewer children. 
Those with eight years or more of education had on 
average 1.7 children while those with less than four 
years of education had 3.7 children.f In the context 
of Brazil’s extreme social heterogeneity, education 
level plays a signifi cant role in determining negative 
health outcomes to an extent not observed in the US 
or Western Europe.
The effect of ART at the time of enrollment in the cohort 
suggested a lower risk of pregnancy. In a cross-sectional 
study conducted by Maier et al between 2005 and 2006 
in Uganda among 501 HIV-positive women aged 18 to 
50 years, ART was signifi cantly associated with reduced 
odds of pregnancy in the previous three years.13 Massad 
et al (2004) reported that between 1994 and 2002 the 
use of non-HAART therapies at the time of inclusion 
in the cohort was associated with a lower chance of 
getting pregnant. In their study, only 11 women were on 
HAART, and no signifi cant associations were found.16 
Given that the use of antiretrovirals is associated to 
more advanced stages of clinical HIV syndrome, the 
hypothesis that women at advanced stages of disease 
would be less likely to become pregnant is plausible. In 
the present study, nonetheless, the univariate analysis 
did not suggest any signifi cant association between 
HIV-related manifestations and the risk of pregnancy.
In contrast, Blair et al (2004) found higher pregnancy 
rates among women on HAART during the previous 
6-month interval compared to those on less potent 
therapeutic regimens.5 This fi nding suggests that partial 
reversion of immunodefi ciency and improvement in 
overall health status brought about by antiretroviral 
therapy may revive reproductive desires among women 
with HIV/AIDS. The lack of consensus among the 
studies could be attributed to the way the variable 
is defi ned and the stage of disease in the population 
studied. In our study, and in Massad et al study, anti-
retroviral use was observed at baseline whereas in Blair 
et al study it was considered a time-dependent variable. 
This seems to be the most appropriate method for 
evaluating this variable given its variability over time 
and the dynamic of related variables such as CD4+ 
T-lymphocyte count and viral load.
We did not fi nd a higher risk of pregnancy among 
women who reported domestic violence and sexual 
abuse. In Nigeria, Olagbuji et al (2010) described in a 
cross-sectional study of 502 women both HIV-positive 
and HIV-negative attending a postnatal clinic a 43.5% 
prevalence of domestic violence during the 12 months 
before pregnancy. HIV seropositivity was signifi cantly 
associated with domestic violence.19 Specifi c strategies 
and counseling are needed for women with HIV/AIDS 
who are victims of domestic violence as they may 
experience repeated unplanned pregnancies.
Our study has some limitations. As it was based on data 
from a single center, the results cannot be generalized 
to other clinical settings or backgrounds in Brazil. 
However, the characteristics of the study population 
are comparable to those of women living with AIDS 
reported to the Brazilian Ministry of Health, which 
increases their comparability. Women who were using 
effective contraception were not excluded from this 
study, although contraception use may have changed 
over time. Despite data about contraception use in the 
previous six months was collected in every study visit, 
the lack of information on start and discontinuation 
dates did not allow us to take contraception use into 
account in estimating the pregnancy rate in our cohort. 
We did not study time-dependent variables, but better 
understanding baseline characteristics associated with 
future pregnancy may help the implementation of 
counseling programs for specifi c subgroups of women. 
Although the study ended in December 2003, our 
results provide an input on future trends in pregnancy 
f Instituto Brasileiro de Geografi a e Estatística. Censo demográfi co. Rio de Janeiro, Brazil; 2000.
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